{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:24:53Z","timestamp":1793413493638,"version":"4.5.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019670","name":"BIKEN Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.vaccine.2023.03.077","type":"journal-article","created":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T17:01:26Z","timestamp":1712422886000},"page":"3134-3143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants\u00a0\u2265\u00a02 and\u00a0&lt;\u00a043 months of Age: A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study"],"prefix":"10.1016","volume":"42","author":[{"given":"Takashi","family":"Nakano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masumi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoshio","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.03.077_b0005","unstructured":"The 6th Meeting of the Subcommittee on Research & Development and Production\/Distribution of the Committee on Vaccination and Vaccine in the Health Sciences Council (November 28, 2013)."},{"key":"10.1016\/j.vaccine.2023.03.077_b0010","unstructured":"Ministry of Health, Labour and Welfare. Basic plan for vaccination. March 28, 2014."},{"key":"10.1016\/j.vaccine.2023.03.077_b0015","unstructured":"WHO Position Paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec. 2006;81(47):445\u201352."},{"issue":"6","key":"10.1016\/j.vaccine.2023.03.077_b0020","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2023.03.077_b0025","first-page":"2275","article-title":"DPT","volume":"53","author":"Kato","year":"1990","journal-title":"J Pediatr Pra"},{"key":"10.1016\/j.vaccine.2023.03.077_b0030","unstructured":"Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare; Infectious Disease Surveillance Center, National Institute of Infectious Diseases. Annual report 2003 National epidemiological surveillance of vaccine-preventable diseases. 2004;162\u201375."},{"key":"10.1016\/j.vaccine.2023.03.077_b0035","unstructured":"Tuberculosis and Infectious Diseases Control Division, Health Service Bureau, Ministry of Health, Labour and Welfare; Infectious Disease Surveillance Center, National Institute of Infectious Diseases. Annual report 2008 National epidemiological surveillance of vaccine-preventable diseases. 2011;217\u201332."},{"key":"10.1016\/j.vaccine.2023.03.077_b0040","unstructured":"WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines. Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in the Gambia, Oman, and Thailand. Bull World Health Organ. 1996;74(3):253\u201368."},{"issue":"7","key":"10.1016\/j.vaccine.2023.03.077_b0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jiac.2019.11.012","article-title":"Immunogenicity and safety of a DTaP-IPV\/Hib pentavalent vaccine given as primary and booster vaccinations in healthy infants and toddlers in Japan","volume":"26","author":"Nakayama","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2023.03.077_b0050","unstructured":"Sanofi K.K. Package insert of ActHIB\u00ae (revised in August 2022, Version 1)."},{"key":"10.1016\/j.vaccine.2023.03.077_b0055","unstructured":"The Research Foundation for Microbial Diseases of Osaka University. Package insert of Tetrabik Subcutaneous Injection Syringe (revised in December 2022, Version 2)."},{"key":"10.1016\/j.vaccine.2023.03.077_b0060","unstructured":"The Research Foundation for Microbial Diseases of Osaka University. Package insert of Gobik Aqueous Suspension Syringes (revised in November 2023, Version 2)."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24003943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T18:32:27Z","timestamp":1725647547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24003943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":12,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S0264410X24003943"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.077","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and safety of adsorbed diphtheria-purified pertussis-tetanus-inactivated polio (Sabin strain)-Haemophilus type b conjugate combined vaccine (DPT-IPV-Hib) in healthy Japanese Infants\u00a0\u2265\u00a02 and\u00a0<\u00a043 months of Age: A phase III, multicenter, active controlled, assessor-blinded, randomized, parallel-group study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.03.077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}